Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment.
Advances in the fields of cancer initiating cells and high-throughput in vivo shRNA screens have highlighted a need to observe the growth of tumor cells in cancer models at the clonal level. While in vivo cancer cell growth heterogeneity in xenografts has been described, it has yet to be measured. H...
Autors principals: | Olivier Nolan-Stevaux, Donato Tedesco, Seamus Ragan, Mikhail Makhanov, Alex Chenchik, Astrid Ruefli-Brasse, Kim Quon, Paul D Kassner |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Public Library of Science (PLoS)
2013-01-01
|
Col·lecció: | PLoS ONE |
Accés en línia: | http://europepmc.org/articles/PMC3693957?pdf=render |
Ítems similars
-
Identification of Genes Specific for Viability of Prostate Cancer Cells using a Pooled Lentiviral shRNA Expression Library
per: D. Tedesco, et al.
Publicat: (2012-03-01) -
165 Microsampling for RNA biomarker profiling in blood
per: Alex Chenchik, et al.
Publicat: (2023-11-01) -
Transduction of Primary AML Cells with Lentiviral Vector for In Vitro Study or In Vivo Engraftment
per: Aaron D. Schimmer, et al.
Publicat: (2020-12-01) -
The unknown impact of conditioning on HSC engraftment and clonal dynamics
per: Stefan Radtke
Publicat: (2023-03-01) -
DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment
per: Duncan R. Hewett, et al.
Publicat: (2017-12-01)